MaxCyte (MXCT) to Release Quarterly Earnings on Tuesday

MaxCyte (NASDAQ:MXCT) will likely be issuing its quarterly earnings data after the market closes on Tuesday, March 11th. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $7.98 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

MaxCyte Stock Performance

Shares of MXCT opened at $3.51 on Monday. The company’s 50 day moving average price is $4.26 and its 200 day moving average price is $4.00. MaxCyte has a 52 week low of $3.16 and a 52 week high of $5.26. The company has a market capitalization of $371.92 million, a PE ratio of -10.32 and a beta of 1.35.

About MaxCyte

MaxCyte, Inc, a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering.